If your scripts weren't going to jump substantially and you thought it would be a longer haul before any decent increase in scripts would take place then you would conserve capital.
Nope not in this case as you hire a new CCO and CFO. These are $250K-$350K a year positions, so it makes little sense for Mike C to make this move unless he has something in his pocket that will play out. Mann Group wouldn't throw any more money at a sinking ship either and why would Deerfield keep delaying the so called inevitable?
Why did the stock jump from .70 to $1.88 and why is the naked shorting continuing along with the constant bashing articles and posts if the company was going under? Its over right? Why bother?
What I see is an uptrend in scripts, revenue and refills, while interest rates are declining rapidly on borrowing shares. We had the big rebalancing from the fall out of the Russell 3000 category, so could some of the shorts get an opportunity to cover? We get a nice flush downward to $1.13 and now a good pop back upwards. Then comes the reduction in interest rates to short the stock as well. I think shorts are starting to slowly cover and I think Mike C is going to drop the hammer on them with some incredible news.
All this nonsense about 400% more insulin needed, insurance still being the major road block, the product doesn't work that well is ridiculous. All I see are testimonials drastically increasing with more people touting the merits of Afrezza and now refills are even trending up.
If I'm short I either cover now or get monkey hammered tomorrow. We are Floyd "Money" Mayweather and the shorts are Connor McGregor with all talk and no hammer. Floyd going to hammer McGregor and so will MNKD hammer the shorts.
